Selected article for: "immune response and vaccination immunity"
Author: Lobo, Niyati; Brooks, Nathan A.; Zlotta, Alexandre R.; Cirillo, Jeffrey D.; Boorjian, Stephen; Black, Peter C.; Meeks, Joshua J.; Bivalacqua, Trinity J.; Gontero, Paolo; Steinberg, Gary D.; McConkey, David; Babjuk, Marko; Alfred Witjes, J.; Kamat, Ashish M.
Title: 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19
  • Cord-id: ryj97c2w
  • Document date: 2021_6_15
    • ID: ryj97c2w
    Snippet: Bacillus Calmette–Guérin (BCG) is the most widely used vaccine worldwide and has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumour immune response, which urologists have harnessed for the treatment of non-muscle-invasive bladder cancer. A growing body of evidence indicates that BCG offers protection against various non-mycobacterial and viral infections. The non-specific effects of BCG occur via the induction of trained immunity and form the basis for the hyp
    Document: Bacillus Calmette–Guérin (BCG) is the most widely used vaccine worldwide and has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumour immune response, which urologists have harnessed for the treatment of non-muscle-invasive bladder cancer. A growing body of evidence indicates that BCG offers protection against various non-mycobacterial and viral infections. The non-specific effects of BCG occur via the induction of trained immunity and form the basis for the hypothesis that BCG vaccination could be used to protect against the severity of coronavirus disease 2019 (COVID-19). This Perspective article highlights key milestones in the 100-year history of BCG and projects its potential role in the COVID-19 pandemic.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory distress syndrome and adaptive immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome and adaptive immune system response: 1, 2
    • acute respiratory distress syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45
    • acute respiratory distress syndrome and adaptive innate response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute respiratory distress syndrome and additional protection: 1
    • acute respiratory distress syndrome and adolescent adult: 1
    • acute respiratory distress syndrome and los angeles: 1, 2, 3, 4, 5
    • acute respiratory distress syndrome and low birth weight: 1, 2, 3
    • acute respiratory distress syndrome and low birth weight neonate: 1
    • acute respiratory distress syndrome and low incidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory distress syndrome and low threshold: 1, 2, 3, 4, 5, 6
    • acute respiratory distress syndrome and lung fluorodeoxyglucose: 1
    • acute respiratory distress syndrome and lymph node: 1, 2
    • acute respiratory distress syndrome and lymphoblastic leukaemia: 1
    • acute respiratory distress syndrome and m1 macrophage: 1, 2, 3, 4, 5, 6
    • acute respiratory distress syndrome and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory distress syndrome develop and adaptive immune system: 1
    • acute respiratory distress syndrome develop and adaptive immunity: 1